nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—ABCG2—Topotecan—cervical cancer	0.539	1	CbGbCtD
Oxaliplatin—CA4—Reversible hydration of carbon dioxide—CA9—cervical cancer	0.0111	0.0995	CbGpPWpGaD
Oxaliplatin—MT1A—renal system—cervical cancer	0.0077	0.022	CbGeAlD
Oxaliplatin—GSTP1—exocrine gland—cervical cancer	0.00718	0.0205	CbGeAlD
Oxaliplatin—ATP7B—endometrium—cervical cancer	0.00667	0.0191	CbGeAlD
Oxaliplatin—MT2A—renal system—cervical cancer	0.00642	0.0183	CbGeAlD
Oxaliplatin—GSTT1—renal system—cervical cancer	0.00628	0.0179	CbGeAlD
Oxaliplatin—MT1A—female reproductive system—cervical cancer	0.00617	0.0176	CbGeAlD
Oxaliplatin—ATP7B—uterus—cervical cancer	0.00615	0.0176	CbGeAlD
Oxaliplatin—ATP7A—epithelium—cervical cancer	0.00599	0.0171	CbGeAlD
Oxaliplatin—ATP7A—uterine cervix—cervical cancer	0.00594	0.017	CbGeAlD
Oxaliplatin—ATP7A—decidua—cervical cancer	0.00566	0.0162	CbGeAlD
Oxaliplatin—ATP7A—renal system—cervical cancer	0.00556	0.0159	CbGeAlD
Oxaliplatin—ATP7B—female reproductive system—cervical cancer	0.00553	0.0158	CbGeAlD
Oxaliplatin—ATP7A—endometrium—cervical cancer	0.00537	0.0154	CbGeAlD
Oxaliplatin—SOD1—uterine cervix—cervical cancer	0.0052	0.0149	CbGeAlD
Oxaliplatin—ATP7A—mammalian vulva—cervical cancer	0.0052	0.0149	CbGeAlD
Oxaliplatin—SOD1—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00517	0.0464	CbGpPWpGaD
Oxaliplatin—MT2A—female reproductive system—cervical cancer	0.00514	0.0147	CbGeAlD
Oxaliplatin—SLC31A1—uterine cervix—cervical cancer	0.00507	0.0145	CbGeAlD
Oxaliplatin—ATP7B—female gonad—cervical cancer	0.00503	0.0144	CbGeAlD
Oxaliplatin—GSTT1—female reproductive system—cervical cancer	0.00503	0.0144	CbGeAlD
Oxaliplatin—ATP7B—vagina—cervical cancer	0.005	0.0143	CbGeAlD
Oxaliplatin—SOD1—decidua—cervical cancer	0.00495	0.0142	CbGeAlD
Oxaliplatin—SLC31A1—renal system—cervical cancer	0.00474	0.0135	CbGeAlD
Oxaliplatin—SOD1—endometrium—cervical cancer	0.0047	0.0134	CbGeAlD
Oxaliplatin—MT2A—female gonad—cervical cancer	0.00468	0.0134	CbGeAlD
Oxaliplatin—GSTM1—renal system—cervical cancer	0.00463	0.0132	CbGeAlD
Oxaliplatin—SLC31A1—endometrium—cervical cancer	0.00458	0.0131	CbGeAlD
Oxaliplatin—SOD1—mammalian vulva—cervical cancer	0.00455	0.013	CbGeAlD
Oxaliplatin—SLC31A1—mammalian vulva—cervical cancer	0.00443	0.0127	CbGeAlD
Oxaliplatin—SOD1—uterus—cervical cancer	0.00433	0.0124	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—PIAS3—cervical cancer	0.00427	0.0383	CbGpPWpGaD
Oxaliplatin—ATP7A—female gonad—cervical cancer	0.00405	0.0116	CbGeAlD
Oxaliplatin—ATP7A—vagina—cervical cancer	0.00402	0.0115	CbGeAlD
Oxaliplatin—SLC31A1—female reproductive system—cervical cancer	0.0038	0.0108	CbGeAlD
Oxaliplatin—GSTM1—female reproductive system—cervical cancer	0.0037	0.0106	CbGeAlD
Oxaliplatin—SLC22A2—renal system—cervical cancer	0.00367	0.0105	CbGeAlD
Oxaliplatin—MPO—C-MYB transcription factor network—PIAS3—cervical cancer	0.00363	0.0326	CbGpPWpGaD
Oxaliplatin—MT1A—lymph node—cervical cancer	0.00361	0.0103	CbGeAlD
Oxaliplatin—SOD1—female gonad—cervical cancer	0.00354	0.0101	CbGeAlD
Oxaliplatin—SOD1—vagina—cervical cancer	0.00352	0.0101	CbGeAlD
Oxaliplatin—NQO1—epithelium—cervical cancer	0.0035	0.00999	CbGeAlD
Oxaliplatin—NQO1—uterine cervix—cervical cancer	0.00347	0.00991	CbGeAlD
Oxaliplatin—SLC31A1—female gonad—cervical cancer	0.00345	0.00987	CbGeAlD
Oxaliplatin—SLC31A1—vagina—cervical cancer	0.00343	0.00981	CbGeAlD
Oxaliplatin—GSTM1—female gonad—cervical cancer	0.00337	0.00963	CbGeAlD
Oxaliplatin—NQO1—decidua—cervical cancer	0.0033	0.00944	CbGeAlD
Oxaliplatin—NQO1—renal system—cervical cancer	0.00324	0.00927	CbGeAlD
Oxaliplatin—ATP7B—lymph node—cervical cancer	0.00323	0.00924	CbGeAlD
Oxaliplatin—MPO—epithelium—cervical cancer	0.00321	0.00919	CbGeAlD
Oxaliplatin—NQO1—endometrium—cervical cancer	0.00313	0.00896	CbGeAlD
Oxaliplatin—GSTP1—epithelium—cervical cancer	0.00312	0.00893	CbGeAlD
Oxaliplatin—GSTP1—uterine cervix—cervical cancer	0.0031	0.00885	CbGeAlD
Oxaliplatin—NQO1—mammalian vulva—cervical cancer	0.00303	0.00867	CbGeAlD
Oxaliplatin—MPO—renal system—cervical cancer	0.00298	0.00852	CbGeAlD
Oxaliplatin—GSTP1—decidua—cervical cancer	0.00295	0.00843	CbGeAlD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-DPB1—cervical cancer	0.00293	0.0262	CbGpPWpGaD
Oxaliplatin—GSTP1—renal system—cervical cancer	0.0029	0.00828	CbGeAlD
Oxaliplatin—NQO1—uterus—cervical cancer	0.00289	0.00826	CbGeAlD
Oxaliplatin—GSTP1—endometrium—cervical cancer	0.0028	0.00801	CbGeAlD
Oxaliplatin—GSTP1—mammalian vulva—cervical cancer	0.00271	0.00774	CbGeAlD
Oxaliplatin—SLC22A3—uterine cervix—cervical cancer	0.00265	0.00757	CbGeAlD
Oxaliplatin—ATP7A—lymph node—cervical cancer	0.0026	0.00744	CbGeAlD
Oxaliplatin—NQO1—female reproductive system—cervical cancer	0.0026	0.00742	CbGeAlD
Oxaliplatin—SLC22A1—renal system—cervical cancer	0.00259	0.00741	CbGeAlD
Oxaliplatin—GSTP1—uterus—cervical cancer	0.00258	0.00738	CbGeAlD
Oxaliplatin—SLC22A3—renal system—cervical cancer	0.00248	0.00708	CbGeAlD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00243	0.0218	CbGpPWpGaD
Oxaliplatin—SLC22A3—endometrium—cervical cancer	0.0024	0.00685	CbGeAlD
Oxaliplatin—NQO1—female gonad—cervical cancer	0.00236	0.00675	CbGeAlD
Oxaliplatin—NQO1—vagina—cervical cancer	0.00235	0.00671	CbGeAlD
Oxaliplatin—MT1A—Copper homeostasis—CASP3—cervical cancer	0.00234	0.021	CbGpPWpGaD
Oxaliplatin—ABCC2—renal system—cervical cancer	0.00233	0.00665	CbGeAlD
Oxaliplatin—GSTP1—female reproductive system—cervical cancer	0.00232	0.00663	CbGeAlD
Oxaliplatin—CYP1B1—decidua—cervical cancer	0.00232	0.00663	CbGeAlD
Oxaliplatin—SLC22A3—mammalian vulva—cervical cancer	0.00232	0.00662	CbGeAlD
Oxaliplatin—MT2A—Interferon gamma signaling—HLA-DQB1—cervical cancer	0.00228	0.0205	CbGpPWpGaD
Oxaliplatin—SOD1—lymph node—cervical cancer	0.00228	0.00651	CbGeAlD
Oxaliplatin—CYP1B1—renal system—cervical cancer	0.00228	0.00651	CbGeAlD
Oxaliplatin—SLC31A1—lymph node—cervical cancer	0.00222	0.00635	CbGeAlD
Oxaliplatin—CA4—renal system—cervical cancer	0.00221	0.00631	CbGeAlD
Oxaliplatin—GSTM1—lymph node—cervical cancer	0.00217	0.00619	CbGeAlD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00212	0.019	CbGpPWpGaD
Oxaliplatin—GSTP1—female gonad—cervical cancer	0.00211	0.00603	CbGeAlD
Oxaliplatin—GSTP1—vagina—cervical cancer	0.0021	0.006	CbGeAlD
Oxaliplatin—CYP1B1—uterus—cervical cancer	0.00203	0.0058	CbGeAlD
Oxaliplatin—SLC22A3—female reproductive system—cervical cancer	0.00198	0.00567	CbGeAlD
Oxaliplatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00193	0.0173	CbGpPWpGaD
Oxaliplatin—SLC22A1—vagina—cervical cancer	0.00188	0.00537	CbGeAlD
Oxaliplatin—ABCC2—female reproductive system—cervical cancer	0.00186	0.00532	CbGeAlD
Oxaliplatin—CYP1B1—female reproductive system—cervical cancer	0.00182	0.00521	CbGeAlD
Oxaliplatin—ABCG2—uterine cervix—cervical cancer	0.00181	0.00518	CbGeAlD
Oxaliplatin—SLC22A3—female gonad—cervical cancer	0.00181	0.00516	CbGeAlD
Oxaliplatin—SLC22A3—vagina—cervical cancer	0.00179	0.00513	CbGeAlD
Oxaliplatin—CYP1B1—Tryptophan metabolism—UBE3A—cervical cancer	0.00177	0.0159	CbGpPWpGaD
Oxaliplatin—ATP7B—Copper homeostasis—CASP3—cervical cancer	0.00177	0.0159	CbGpPWpGaD
Oxaliplatin—CA4—female reproductive system—cervical cancer	0.00177	0.00505	CbGeAlD
Oxaliplatin—CYP1A1—epithelium—cervical cancer	0.00174	0.00496	CbGeAlD
Oxaliplatin—ABCG2—decidua—cervical cancer	0.00173	0.00494	CbGeAlD
Oxaliplatin—CYP1A1—uterine cervix—cervical cancer	0.00172	0.00492	CbGeAlD
Oxaliplatin—ATP7A—Cellular responses to stress—CA9—cervical cancer	0.00171	0.0153	CbGpPWpGaD
Oxaliplatin—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cervical cancer	0.00166	0.0149	CbGpPWpGaD
Oxaliplatin—CYP1B1—female gonad—cervical cancer	0.00166	0.00474	CbGeAlD
Oxaliplatin—ABCG2—endometrium—cervical cancer	0.00164	0.00469	CbGeAlD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00163	0.0147	CbGpPWpGaD
Oxaliplatin—CYP1A2—renal system—cervical cancer	0.00163	0.00466	CbGeAlD
Oxaliplatin—CYP1A1—renal system—cervical cancer	0.00161	0.0046	CbGeAlD
Oxaliplatin—CA4—female gonad—cervical cancer	0.00161	0.0046	CbGeAlD
Oxaliplatin—ABCG2—mammalian vulva—cervical cancer	0.00159	0.00453	CbGeAlD
Oxaliplatin—SOD1—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.00156	0.0139	CbGpPWpGaD
Oxaliplatin—NQO1—lymph node—cervical cancer	0.00152	0.00434	CbGeAlD
Oxaliplatin—ABCG2—uterus—cervical cancer	0.00151	0.00432	CbGeAlD
Oxaliplatin—ATP7A—Copper homeostasis—CASP3—cervical cancer	0.00151	0.0135	CbGpPWpGaD
Oxaliplatin—CYP1A1—mammalian vulva—cervical cancer	0.00151	0.0043	CbGeAlD
Oxaliplatin—MT1A—Copper homeostasis—TP53—cervical cancer	0.0015	0.0134	CbGpPWpGaD
Oxaliplatin—CYP2E1—renal system—cervical cancer	0.00147	0.0042	CbGeAlD
Oxaliplatin—SLC31A1—Copper homeostasis—CASP3—cervical cancer	0.00144	0.0129	CbGpPWpGaD
Oxaliplatin—CYP1A1—uterus—cervical cancer	0.00143	0.0041	CbGeAlD
Oxaliplatin—MT2A—Interferon Signaling—HLA-DPB1—cervical cancer	0.00143	0.0128	CbGpPWpGaD
Oxaliplatin—MT2A—Copper homeostasis—CASP3—cervical cancer	0.00142	0.0127	CbGpPWpGaD
Oxaliplatin—MPO—lymph node—cervical cancer	0.0014	0.00399	CbGeAlD
Oxaliplatin—GSTP1—lymph node—cervical cancer	0.00136	0.00388	CbGeAlD
Oxaliplatin—MPO—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.00136	0.0122	CbGpPWpGaD
Oxaliplatin—CYP1A1—female reproductive system—cervical cancer	0.00129	0.00368	CbGeAlD
Oxaliplatin—SOD1—Folate Metabolism—MTHFR—cervical cancer	0.00127	0.0113	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—GP6—cervical cancer	0.00125	0.0112	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—SERPIND1—cervical cancer	0.00125	0.0112	CbGpPWpGaD
Oxaliplatin—ABCG2—female gonad—cervical cancer	0.00124	0.00353	CbGeAlD
Oxaliplatin—ABCG2—vagina—cervical cancer	0.00123	0.00351	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—HES1—cervical cancer	0.00122	0.0109	CbGpPWpGaD
Oxaliplatin—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0012	0.0108	CbGpPWpGaD
Oxaliplatin—CYP2E1—female reproductive system—cervical cancer	0.00118	0.00336	CbGeAlD
Oxaliplatin—CYP1A1—female gonad—cervical cancer	0.00117	0.00335	CbGeAlD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00117	0.0105	CbGpPWpGaD
Oxaliplatin—CYP1A1—vagina—cervical cancer	0.00117	0.00333	CbGeAlD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—CASP3—cervical cancer	0.00117	0.0105	CbGpPWpGaD
Oxaliplatin—SLC22A3—lymph node—cervical cancer	0.00116	0.00332	CbGeAlD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.00116	0.0104	CbGpPWpGaD
Oxaliplatin—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.00116	0.0104	CbGpPWpGaD
Oxaliplatin—ATP7B—Copper homeostasis—TP53—cervical cancer	0.00114	0.0102	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—CD4—cervical cancer	0.00113	0.0101	CbGpPWpGaD
Oxaliplatin—MT2A—Interferon Signaling—HLA-DQB1—cervical cancer	0.00112	0.01	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—MTHFR—cervical cancer	0.0011	0.0099	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—GP5—cervical cancer	0.00109	0.00981	CbGpPWpGaD
Oxaliplatin—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.00109	0.00979	CbGpPWpGaD
Oxaliplatin—ABCC2—lymph node—cervical cancer	0.00109	0.00311	CbGeAlD
Oxaliplatin—MT2A—AP-1 transcription factor network—CTNNB1—cervical cancer	0.00108	0.00965	CbGpPWpGaD
Oxaliplatin—CYP1B1—lymph node—cervical cancer	0.00107	0.00305	CbGeAlD
Oxaliplatin—MPO—C-MYB transcription factor network—HES1—cervical cancer	0.00104	0.00929	CbGpPWpGaD
Oxaliplatin—CA4—lymph node—cervical cancer	0.00103	0.00296	CbGeAlD
Oxaliplatin—SOD1—Cellular responses to stress—CA9—cervical cancer	0.00103	0.00922	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00101	0.00901	CbGpPWpGaD
Oxaliplatin—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.000997	0.00894	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—CASP8—cervical cancer	0.00099	0.00888	CbGpPWpGaD
Oxaliplatin—ATP7A—Copper homeostasis—TP53—cervical cancer	0.000966	0.00866	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-DPB1—cervical cancer	0.000954	0.00856	CbGpPWpGaD
Oxaliplatin—CYP1B1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000943	0.00846	CbGpPWpGaD
Oxaliplatin—SLC31A1—Copper homeostasis—TP53—cervical cancer	0.000926	0.0083	CbGpPWpGaD
Oxaliplatin—MT2A—Copper homeostasis—TP53—cervical cancer	0.000908	0.00814	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—CASP3—cervical cancer	0.000907	0.00813	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CA9—cervical cancer	0.000897	0.00805	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000877	0.00787	CbGpPWpGaD
Oxaliplatin—MPO—IL23-mediated signaling events—STAT3—cervical cancer	0.000873	0.00783	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000819	0.00734	CbGpPWpGaD
Oxaliplatin—ABCG2—lymph node—cervical cancer	0.000794	0.00227	CbGeAlD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000785	0.00704	CbGpPWpGaD
Oxaliplatin—CYP1A1—lymph node—cervical cancer	0.000754	0.00216	CbGeAlD
Oxaliplatin—SOD1—AGE/RAGE pathway—CASP3—cervical cancer	0.000749	0.00672	CbGpPWpGaD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.000747	0.0067	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.000745	0.00668	CbGpPWpGaD
Oxaliplatin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000723	0.00648	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—TP53—cervical cancer	0.000716	0.00642	CbGpPWpGaD
Oxaliplatin—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000696	0.00625	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CD4—cervical cancer	0.000688	0.00617	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000649	0.00582	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000649	0.00582	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—STAT3—cervical cancer	0.000629	0.00565	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CD4—cervical cancer	0.000585	0.00525	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—TP53—cervical cancer	0.000581	0.00521	CbGpPWpGaD
Oxaliplatin—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000581	0.00521	CbGpPWpGaD
Oxaliplatin—SOD1—AGE/RAGE pathway—EGFR—cervical cancer	0.000572	0.00513	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—UBE3A—cervical cancer	0.000522	0.00468	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000484	0.00434	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TP53—cervical cancer	0.00048	0.00431	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000469	0.00421	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—MTOR—cervical cancer	0.000446	0.004	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TP53—cervical cancer	0.000419	0.00376	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—CA9—cervical cancer	0.000395	0.00354	CbGpPWpGaD
Oxaliplatin—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00037	0.00332	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—STAT3—cervical cancer	0.000345	0.00309	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000312	0.0028	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000312	0.0028	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-DPB1—cervical cancer	0.000312	0.0028	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000311	0.00279	CbGpPWpGaD
Oxaliplatin—MT2A—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000309	0.00277	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000308	0.00277	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—MTOR—cervical cancer	0.000269	0.00241	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—TP53—cervical cancer	0.000263	0.00236	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—CA9—cervical cancer	0.000254	0.00228	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—HLA-DQB1—cervical cancer	0.000243	0.00218	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—MTOR—cervical cancer	0.000234	0.0021	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD8A—cervical cancer	0.000227	0.00204	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—CA9—cervical cancer	0.000226	0.00202	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—CA9—cervical cancer	0.000216	0.00194	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—CA9—cervical cancer	0.000211	0.00189	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—STAT3—cervical cancer	0.000208	0.00186	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000192	0.00172	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000192	0.00172	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—FGFR3—cervical cancer	0.000186	0.00167	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—STAT3—cervical cancer	0.000181	0.00162	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—MTHFR—cervical cancer	0.00016	0.00144	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CASP8—cervical cancer	0.000159	0.00143	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TP53—cervical cancer	0.000158	0.00142	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—CA9—cervical cancer	0.000145	0.0013	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TP53—cervical cancer	0.000138	0.00124	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—MTOR—cervical cancer	0.000131	0.00117	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD4—cervical cancer	0.000131	0.00117	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000123	0.0011	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000123	0.0011	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CTNNB1—cervical cancer	0.000116	0.00104	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—MTHFR—cervical cancer	0.000103	0.000925	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—CA9—cervical cancer	0.000101	0.000908	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—STAT3—cervical cancer	0.000101	0.000906	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TP53—cervical cancer	9.42e-05	0.000845	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—CA9—cervical cancer	9.21e-05	0.000826	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—EGFR—cervical cancer	9.18e-05	0.000824	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—MTHFR—cervical cancer	9.15e-05	0.000821	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—CA9—cervical cancer	9.11e-05	0.000817	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—MTHFR—cervical cancer	8.77e-05	0.000787	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—MTHFR—cervical cancer	8.55e-05	0.000767	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—CA9—cervical cancer	8.5e-05	0.000762	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—CA9—cervical cancer	6.61e-05	0.000593	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—CA9—cervical cancer	6.23e-05	0.000559	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—MTHFR—cervical cancer	5.9e-05	0.000529	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—MTHFR—cervical cancer	4.11e-05	0.000368	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—CA9—cervical cancer	3.97e-05	0.000357	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—MTHFR—cervical cancer	3.74e-05	0.000335	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—MTHFR—cervical cancer	3.7e-05	0.000332	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—MTHFR—cervical cancer	3.45e-05	0.000309	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—MTHFR—cervical cancer	2.68e-05	0.000241	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—MTHFR—cervical cancer	2.53e-05	0.000227	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—MTHFR—cervical cancer	1.61e-05	0.000145	CbGpPWpGaD
